ReportWire
[ad_1]
Pfizer Stock Gains After Earnings Beat. Revenue and Outlook Aren’t So Good.
[ad_2]
Source link
Pfizer Agrees to Buy Seagen for $43 Billion
Seagen (SGEN) Receives a Buy from Needham
In a report released today, Ami Fadia from Needham maintained a Buy rating on Seagen (SGEN – Research Report), with a price target of $160.00. The company’s shares closed yesterday at $131.25.According to TipRanks, Fadia i…
Oct. 28, 2022 at 6:05 a.m. ET
on TipRanks.com